Cartesian Therapeutics (RNAC) Debt Ratio (2015 - 2023)

Cartesian Therapeutics (RNAC) has 9 years of Debt Ratio data on file, last reported at 0.09 in Q4 2023.

• Debt Ratio for Q4 2023 came in at 0.09, down 13.45% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.09 (down 13.45% YoY), and the FY2023 annual result was 0.09, down 13.45% from the prior year.
• Debt Ratio eased to 0.09 in Q4 2023 per RNAC's latest filing, from 0.17 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.53 in Q3 2019 and troughed at 0.09 in Q4 2023.
• A 5-year average of 0.2 and a median of 0.16 in 2021 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2019 and 2020: Debt Ratio soared 58.9% in 2019, then sank 74.33% in 2020.
• A 5-year view of Debt Ratio shows it stood at 0.19 in 2019, then slipped by 21.07% to 0.15 in 2020, then climbed by 6.98% to 0.16 in 2021, then plunged by 33.13% to 0.11 in 2022, then decreased by 13.45% to 0.09 in 2023.
• Business Quant data shows RNAC's Debt Ratio at 0.09 in Q4 2023, 0.17 in Q2 2023, and 0.17 in Q1 2023.